About us. The Austrian Breast & Colorectal Cancer Study Group (ABCSG) is Austria’s biggest and best-established academic research organization that conducts internationally respected clinical trials to investigate breast and colon cancer. Austrian Breast & Colorectal Cancer Study Group Science from the heart of Europe. Unterstützen Sie unsere Forschung mit Ihrer Spende! Home; Die ABCSG. ABCSG – Austrian Breast & Colorectal Cancer Study Group. Klinische Studien mit Know-How und Qualität; Unabhängige akademische Krebsforschung aus Österreich; 7. Post-SABCS am
Jan 15, · Methods. A matched case-control study was conducted utilizing the Austrian Breast and Colorectal Cancer Study Group Trial 8 that randomized post-menopausal women with estrogen receptor positive breast cancer to tamoxifen for 5 years (Arm A) or tamoxifen for 2 years followed by anastrozole for 3 years (Arm B).Cited by: Research outputs, collaborations and relationships for Austrian Breast and Colorectal Cancer Study Group (ABCSG) published between 1 July - 30 June as tracked by the Nature Index.
Mar 10, · Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence bihada-josei.info by: Wolfgang Eisterer, Gudrun Piringer, Alexander De Vries, Dietmar Öfner, Richard Greil, Jörg Tschmelitsch, Hellmut Samonigg, Lidija Sölkner, Michael Gnant and Josef Thaler On behalf of the Austrian Breast and Colorectal Cancer Study Group. Anticancer Res. May;37(5) Download Publikation.